Science
By Carl-Johan Dalsgaard, CEO of Vicore Pharma The rapid development, and now distribution, of COVID-19 vaccines is welcome progress in the global fight against this pervasive and mutating virus. But we are far from being out of the woods yet. Recent data show that the Pfizer and Moderna vaccines are… Read more
Science
It’s been a very busy few months at Vicore as we’ve continued to progress our studies into IPF and of course our COVID study, ATTRACT. As we now have some initial top line positive results from ATTRACT, we asked CMO Rohit Batta to talk about what the ATTRACT results might… Read more
Science
By Rohit Batta, CMO of Vicore Pharma Not being able to go out much during the UK lockdown made me wonder how IPF patients cope with the challenges they face in terms of social isolation. Lots of us experienced lockdown, and a sense of isolation, but have since been able… Read more
Science
The Renin-Angiontensin System (RAS) has been studied for nearly 100 years, but there were some unexpected findings about it made only in the 1990s. These findings have been the scientific foundation of much of our development work at Vicore. Vicore CMO, Rohit Batta, spoke about this journey during his presentation… Read more
Science
Vicore CMO Rohit Batta has been making progress with our ATTRACT study, which will investigate a potential treatment for COVID-19. Here’s Rohit’s report on what’s been happening: There’s an element of serendipity in how this study came about. As the details of how COVID-19 acts on the body became known,… Read more
Science
There aren’t that many articles written to provide a practical guide to how a pulmonologist might approach a patient with suspected IPF – the real challenges. We found this article by Dr Aaron B. Holley; it is a gem, and certainly worth a read, especially when taking standard… Read more
Science